SELECT FROM MENU

Therapy Area
Drug Classes

       Disease Area

All Sessions

All Sessions

All Sessions

Resectable NSCLC

All Sessions

Metastatic NSCLC

All Sessions

SCLC

All Sessions

Biomarkers

       Drug Class

Targeted Therapies

Targeted Therapies

Immuno-therapies

Immuno-therapies

Antibody-Drug Conjugates

Antibody-Drug Conjugates

Sze Wai Chan

Sze Wai Chan

Sandton Oncology, Johannesburg

Dr. Sze-Wai Chan is a medical oncologist and director of clinical research at Sandton Oncology in Johannesburg, South Africa. Her main clinical and research interests are lung cancer, melanoma and skin cancer, and head, neck and urogenital cancers, building on her MMed thesis on EGFR mutations in non-small cell lung cancer in South Africa. She serves as principal and sub-investigator on local and international clinical trials, sat on the scientific programme committee for WCLC 2025 in Barcelona, is an executive member of SASMO since 2022, and is vice president of the Melanoma Society South Africa. She is a frequent speaker at major international thoracic oncology congresses.

Connect

Sze Wai Chan

Featured in

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Indication Areas

All Sessions

All Sessions

Resectable NSCLC

Resectable NSCLC

Metastatic Lung Cancer

Metastatic NSCLC

Lung Cancer

SCLC

Biomarkers

Biomarkers & Diagnostics

DRUG CLASSES

Pill

Targeted Therapies

OncoNews

Immunotherapies

Antibody Drug Conjugates

Antibody-Drug Conjugates